Mail-order patients go generic

Here's an unlikely enemy for brand-name drugmakers: mail-order pharmacies. Patients who fill their scrips via mail order are much more likely to choose generic drugs, according to two new studies. The exact figure was 34 percent more likely, which study sponsor Express Scripts hailed as a money-saver, but Pharma might lament as a revenue-drainer.

Two pieces of good news, though. The study only covered blood pressure meds, so generic choice might vary for other therapeutic classes. And if patients do order brand-name drugs via mail order, they're likely to be repeat customers. Compliance among mail-order patients was a full seven percentage points higher than among those who use retail pharmacies.

- read the Express Scripts release

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.